Valuation: Rani Therapeutics Holdings, Inc.

Market Cap 76.77M 67.41M 62.04M 57.82M 109M 7.3B 111M 746M 289M 3.58B 288M 282M 12.47B P/E 2026 *
-3.97x
P/E 2027 * -3.49x
Enterprise Value 76.77M 67.41M 62.04M 57.82M 109M 7.3B 111M 746M 289M 3.58B 288M 282M 12.47B EV / Sales 2026 *
18.6x
EV / Sales 2027 * 15.6x
Free-Float
78.28%
Yield 2026 *
-
Yield 2027 * -
1 day+1.05%
1 week+0.18%
Current month+1.05%
1 month-14.21%
3 months-4.59%
6 months-43.08%
Current year-43.08%
1 week 0.72
Extreme 0.72
0.78
1 month 0.72
Extreme 0.72
0.92
Current year 0.68
Extreme 0.68
1.54
1 year 0.39
Extreme 0.387
3.87
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Chairman 69 01/06/2021
Director/Board Member 80 01/09/2018
Director/Board Member 69 06/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-03Free

Founder

3,800,000 3.8106%
06-03Free

Executive/Senior Manager

805,500 0.8077%
06-03Free

Chief Technology Officer

805,500 0.8077%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%+0.18%+49.64%-81.35% 76.77M
+1.99%+3.53%+73.02%+131.65% 56.21B
+0.55%+8.49%+77.09%+100.93% 55.38B
+0.93%+4.11%-12.64%-12.98% 23.75B
+0.36%+3.42%+9.61%+407.11% 23.19B
+3.35%+8.04%+39.42%-6.14% 18.14B
+1.96%+7.06%+42.17%-28.94% 16.84B
+1.49%+17.24%+174.91%+344.55% 15.86B
-0.83%+2.06%+23.70%+182.37% 13.56B
+6.69%+12.80%+41.46% - 12.97B
Average +1.76%+6.26%+51.84%+115.24% 23.6B
Weighted average by Cap. +1.55%+6.60%+56.61%+132.08%

Financials

2026 *2027 *
Net sales 4.13M 3.62M 3.34M 3.11M 5.86M 392M 5.98M 40.12M 15.54M 193M 15.5M 15.16M 670M 4.92M 4.32M 3.98M 3.71M 6.99M 468M 7.14M 47.87M 18.55M 230M 18.49M 18.09M 800M
Net income -33.21M -29.16M -26.84M -25.01M -47.17M -3.16B -48.13M -323M -125M -1.55B -125M -122M -5.39B -39.93M -35.06M -32.27M -30.07M -56.71M -3.8B -57.86M -388M -150M -1.86B -150M -147M -6.48B
Net Debt - -
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
01/07/26 $0.7684 +1.05% 473,116
30/06/26 $0.7604 -0.56% 213,003
29/06/26 $0.7647 +3.91% 545,525
26/06/26 $0.7359 -0.86% 830,349
25/06/26 $0.7423 -3.22% 461,037
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7684USD
Average target price
7.500USD
Spread / Average Target
+876.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RANI Stock